These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27553907)

  • 1. Metastatic Colorectal Cancer in Hispanics: Treatment Outcomes in a Treated Population.
    Shabihkhani M; Yu SS; Yang D; Lin S; Hamilton AS; Lenz HJ; Barzi A
    Clin Colorectal Cancer; 2016 Dec; 15(4):e221-e227. PubMed ID: 27553907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of racial disparities in the treatment and outcomes of colorectal cancer in young adults.
    Alese OB; Jiang R; Zakka KM; Wu C; Shaib W; Akce M; Behera M; El-Rayes BF
    Cancer Epidemiol; 2019 Dec; 63():101618. PubMed ID: 31600666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care.
    Liss DT; Baker DW
    Am J Prev Med; 2014 Mar; 46(3):228-36. PubMed ID: 24512861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial/Ethnic Disparities in Survival Among Patients With Young-Onset Colorectal Cancer.
    Holowatyj AN; Ruterbusch JJ; Rozek LS; Cote ML; Stoffel EM
    J Clin Oncol; 2016 Jun; 34(18):2148-56. PubMed ID: 27138583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of health insurance and race with treatment and survival in patients with metastatic colorectal cancer.
    Mitsakos AT; Irish W; Parikh AA; Snyder RA
    PLoS One; 2022; 17(2):e0263818. PubMed ID: 35176030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).
    Goldstein J; Tran B; Ensor J; Gibbs P; Wong HL; Wong SF; Vilar E; Tie J; Broaddus R; Kopetz S; Desai J; Overman MJ
    Ann Oncol; 2014 May; 25(5):1032-8. PubMed ID: 24585723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rising Incidence of Colorectal Cancer Among Young Hispanics in Texas.
    Wang DY; Thrift AP; Zarrin-Khameh N; Wichmann A; Armstrong GN; Thompson PA; Bondy ML; Musher BL
    J Clin Gastroenterol; 2017 Jan; 51(1):34-42. PubMed ID: 27956718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of racial/ethnic colorectal cancer screening disparities.
    Jerant AF; Fenton JJ; Franks P
    Arch Intern Med; 2008 Jun; 168(12):1317-24. PubMed ID: 18574089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes Among Minority Patients With Metastatic Colorectal Cancer in a Safety-net Health Care System.
    Lau-Min K; Prakash P; Jo E; Thrift AP; Hilsenbeck S; Musher BL
    Clin Colorectal Cancer; 2020 Jun; 19(2):e49-e57. PubMed ID: 32165040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of socioeconomic status and treatment disparities in colorectal cancer survival.
    Le H; Ziogas A; Lipkin SM; Zell JA
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):1950-62. PubMed ID: 18708384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial Disparities in the Presentation and Treatment of Colorectal Cancer: A Statewide Cross-sectional Study.
    Rodriguez EA; Tamariz L; Palacio A; Li H; Sussman DA
    J Clin Gastroenterol; 2018 Oct; 52(9):817-820. PubMed ID: 29095418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Biologic Agents Among Hispanic Patients With Metastatic Colorectal Cancer.
    Patel R; Negassa A; Tolu SS; Acuna-Villaorduna A; Goel S
    Clin Colorectal Cancer; 2024 Mar; 23(1):14-21.e1. PubMed ID: 37919185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial.
    Ng K; Nimeiri HS; McCleary NJ; Abrams TA; Yurgelun MB; Cleary JM; Rubinson DA; Schrag D; Miksad R; Bullock AJ; Allen J; Zuckerman D; Chan E; Chan JA; Wolpin BM; Constantine M; Weckstein DJ; Faggen MA; Thomas CA; Kournioti C; Yuan C; Ganser C; Wilkinson B; Mackintosh C; Zheng H; Hollis BW; Meyerhardt JA; Fuchs CS
    JAMA; 2019 Apr; 321(14):1370-1379. PubMed ID: 30964527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in incidence of early- and late-onset colorectal cancer between Hispanics and Whites: A 10-year SEER database study.
    Koblinski J; Jandova J; Nfonsam V
    Am J Surg; 2018 Apr; 215(4):581-585. PubMed ID: 28388972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer: The FRESCO Randomized Clinical Trial.
    Li J; Qin S; Xu RH; Shen L; Xu J; Bai Y; Yang L; Deng Y; Chen ZD; Zhong H; Pan H; Guo W; Shu Y; Yuan Y; Zhou J; Xu N; Liu T; Ma D; Wu C; Cheng Y; Chen D; Li W; Sun S; Yu Z; Cao P; Chen H; Wang J; Wang S; Wang H; Fan S; Hua Y; Su W
    JAMA; 2018 Jun; 319(24):2486-2496. PubMed ID: 29946728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High- versus low-dose leucovorin in the modified FOLFOX6 regimen for first-line treatment of metastatic colorectal cancer.
    Reynolds J; Chamberland-Tremblay A; Herrington JD; Munoz Maldonado Y; Wong L
    J Oncol Pharm Pract; 2017 Apr; 23(3):173-178. PubMed ID: 26786027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial Disparities in Clinical Presentation and Survival Times Among Young-Onset Colorectal Adenocarcinoma.
    Arshad HMS; Kabir C; Tetangco E; Shah N; Raddawi H
    Dig Dis Sci; 2017 Sep; 62(9):2526-2531. PubMed ID: 28631085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent differences in first-line chemotherapy in patients with metastatic colorectal cancer: the DISCO study.
    Lund CM; Vistisen KK; Dehlendorff C; Rønholt F; Johansen JS; Nielsen DL
    Acta Oncol; 2018 Nov; 57(11):1445-1454. PubMed ID: 30375911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome disparities in colorectal cancer: a SEER-based comparative analysis of racial subgroups.
    Al-Husseini MJ; Saad AM; Jazieh KA; Elmatboly AM; Rachid A; Gad MM; Ruhban IA; Hilal T
    Int J Colorectal Dis; 2019 Feb; 34(2):285-292. PubMed ID: 30443675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening among Hispanics in the United States: Disparities, modalities, predictors, and regional variation.
    Viramontes O; Bastani R; Yang L; Glenn BA; Herrmann AK; May FP
    Prev Med; 2020 Sep; 138():106146. PubMed ID: 32473957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.